ARTICLE | Company News
PHA returns rights to InSite Vision
May 10, 2001 7:00 AM UTC
ISV said Pharmacia (PHA) returned the worldwide development and marketing rights for its ISV-205 diclofenac non-steroidal anti-inflammatory to treat glaucoma following completion of a Phase IIb study....